These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27772545)

  • 1. In the Red: Deficits in Immune Regulation Underlie Psoriasis Severity.
    Johnston A
    J Invest Dermatol; 2016 Nov; 136(11):2124-2126. PubMed ID: 27772545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Spectrum of Mild to Severe Psoriasis Vulgaris Is Defined by a Common Activation of IL-17 Pathway Genes, but with Key Differences in Immune Regulatory Genes.
    Kim J; Bissonnette R; Lee J; Correa da Rosa J; Suárez-Fariñas M; Lowes MA; Krueger JG
    J Invest Dermatol; 2016 Nov; 136(11):2173-2182. PubMed ID: 27185339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis.
    Nakajima K
    J Dermatol; 2012 Mar; 39(3):219-24. PubMed ID: 22352845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unopposed IL-36 Activity Promotes Clonal CD4
    Arakawa A; Vollmer S; Besgen P; Galinski A; Summer B; Kawakami Y; Wollenberg A; Dornmair K; Spannagl M; Ruzicka T; Thomas P; Prinz JC
    J Invest Dermatol; 2018 Jun; 138(6):1338-1347. PubMed ID: 29288651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
    J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis.
    Sofen H; Smith S; Matheson RT; Leonardi CL; Calderon C; Brodmerkel C; Li K; Campbell K; Marciniak SJ; Wasfi Y; Wang Y; Szapary P; Krueger JG
    J Allergy Clin Immunol; 2014 Apr; 133(4):1032-40. PubMed ID: 24679469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
    Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
    J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10.
    Zanin-Zhorov A; Weiss JM; Trzeciak A; Chen W; Zhang J; Nyuydzefe MS; Arencibia C; Polimera S; Schueller O; Fuentes-Duculan J; Bonifacio KM; Kunjravia N; Cueto I; Soung J; Fleischmann RM; Kivitz A; Lebwohl M; Nunez M; Woodson J; Smith SL; West RF; Berger M; Krueger JG; Ryan JL; Waksal SD
    J Immunol; 2017 May; 198(10):3809-3814. PubMed ID: 28389592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Sodium Accumulates in Psoriasis and Reflects Disease Severity.
    Maifeld A; Wild J; Karlsen TV; Rakova N; Wistorf E; Linz P; Jung R; Birukov A; Gimenez-Rivera VA; Wilck N; Bartolomaeus T; Dechend R; Kleinewietfeld M; Forslund SK; Krause A; Kokolakis G; Philipp S; Clausen BE; Brand A; Waisman A; Kurschus FC; Wegner J; Schultheis M; Luft FC; Boschmann M; Kelm M; Wiig H; Kuehne T; Müller DN; Karbach S; Markó L
    J Invest Dermatol; 2022 Jan; 142(1):166-178.e8. PubMed ID: 34237339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrichment of Polyfunctional IL-17-Producing T Cells in Paradoxical Psoriasis Skin Lesions.
    Moran B; Gallagher C; Tobin AM; Fletcher JM
    J Invest Dermatol; 2020 May; 140(5):1094-1097. PubMed ID: 31682840
    [No Abstract]   [Full Text] [Related]  

  • 11. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
    Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
    J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
    Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
    J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistent skin lesions of vitiligo and psoriasis vulgaris. Immunohistochemical analyses for IL-17A-producing cells and regulatory T cells.
    Ono S; Tanizaki H; Otsuka A; Endo Y; Koyanagi I; Kataoka TR; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2014 May; 94(3):329-30. PubMed ID: 24129673
    [No Abstract]   [Full Text] [Related]  

  • 15. Molecular Mechanisms and Management of a Cutaneous Inflammatory Disorder: Psoriasis.
    Woo YR; Cho DH; Park HJ
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.
    Jones SA; Perera DN; Fan H; Russ BE; Harris J; Morand EF
    J Autoimmun; 2015 Jul; 61():73-80. PubMed ID: 26077873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous application of leukotriene B4 as an in vivo model of psoriasis-like skin inflammation: an immunohistological study.
    Hendriks AG; Keijsers RR; Seyger MM; van de Kerkhof PC; van Erp PE
    Skin Pharmacol Physiol; 2014; 27(3):120-6. PubMed ID: 24401330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antrodia cinnamomea Extract Inhibits Th17 Cell Differentiation and Ameliorates Imiquimod-Induced Psoriasiform Skin Inflammation.
    Li MH; Wu HC; Yao HJ; Lin CC; Wen SF; Pan IH
    Am J Chin Med; 2015; 43(7):1401-17. PubMed ID: 26477794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-23 promotes CD103-negative Th17 in psoriatic non-lesional skin.
    Matsumura Y; Watanabe R; Vo S; Koguchi-Yoshioka H; Furuta J; Inoue S; Ishitsuka Y; Nakamura Y; Okiyama N; Fujisawa Y; Fujimoto M
    J Dermatol Sci; 2021 Jan; 101(1):72-74. PubMed ID: 33143963
    [No Abstract]   [Full Text] [Related]  

  • 20. T-helper 17 cells: the driving force of psoriasis and psoriatic arthritis.
    Yoo IS; Lee JH; Song ST; Kim JH; Lee HJ; Kang SW
    Int J Rheum Dis; 2012 Dec; 15(6):531-7. PubMed ID: 23253236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.